These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 7005730)

  • 21. Prolongation of canine renal allograft survival by using a synthetic progestin in combination with azathioprine and antithymocyte globulin.
    Yellin JA; Enein AA; Goldson H; Hong J; Prince B; Sakai A; Kountz SL
    Surg Forum; 1977; 28():309-11. PubMed ID: 364721
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of immunosuppressive agents and matching on pulmonary allografts.
    Motlagh FA; Dutta SK; Paley N; Karlson KE; Garzon AA
    Surg Forum; 1970; 21():196-8. PubMed ID: 4936968
    [No Abstract]   [Full Text] [Related]  

  • 23. Trial of rabbit antihuman ALG in cadaver kidney transplantation.
    Davis RC; Glasgow AH; Williams LF; Nabseth DC; Olsson CA; Schmitt GW; Idelson BA; Cooperband SR; Harrington JT; Mannick JA
    Transplant Proc; 1971 Mar; 3(1):766-8. PubMed ID: 4937970
    [No Abstract]   [Full Text] [Related]  

  • 24. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
    Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
    Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of ALG and ATG in clinical renal transplantation--recent European experience.
    Groth CG
    Transplant Proc; 1981 Mar; 13(1 Pt 1):460-1. PubMed ID: 7022873
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo - in vitro correlates of antithymocyte globulin (ATG) immunosuppression in the human.
    Thomas F; Berry R; Mendez-Picon G; Thomas J; Lower RR; Lee HM
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():56-61. PubMed ID: 386321
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical experience with antilymphocyte globulin (ALG) in renal transplantation.
    Deodhar SD; Konomi K; Nakamoto S; Kuruvila KC
    Transplant Proc; 1971 Mar; 3(1):758-61. PubMed ID: 4937968
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiac xenotransplantation in primates.
    Sadeghi AM; Robbins RC; Smith CR; Kurlansky PA; Michler RE; Reemtsma K; Rose EA
    J Thorac Cardiovasc Surg; 1987 Jun; 93(6):809-14. PubMed ID: 3553747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A human case of allogeneic heart transplantation compatible in the HL-A system and treated by a heterologous anti-lymphocyte globulin.
    Dubost C; Cachera JP
    Transplant Proc; 1969 Jun; 1(2):693-702. PubMed ID: 4107071
    [No Abstract]   [Full Text] [Related]  

  • 30. Uses of antilymphocyte globulin in renal transplantation.
    Novick AC
    Urol Clin North Am; 1983 May; 10(2):253-62. PubMed ID: 6344386
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of some immunosuppressive agents on blastogenesis and target-cell lysis in vitro.
    Cordier G; Roux C; Revillard JP
    Int Arch Allergy Appl Immunol; 1973; 45(1):299-303. PubMed ID: 4269521
    [No Abstract]   [Full Text] [Related]  

  • 32. A randomized prospective clinical trial of antilymphocyte globulin in 100 cadaveric renal transplants.
    Sansom JR; Barnes AD; Hall CL
    Postgrad Med J; 1976; 52(5 Suppl):75-8. PubMed ID: 792851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Indications and results of renal transplantation].
    Reveillaud RJ; Leski M; Crosnier J
    Presse Med (1893); 1970 Apr; 78(17):795-800. PubMed ID: 4191587
    [No Abstract]   [Full Text] [Related]  

  • 34. Renal transplantation: present status.
    Rubin AL; Whitsell JC; Riggio RR; Schwartz GH; David DS; Stenzel KH
    Bull N Y Acad Med; 1970 Oct; 46(10):869-83. PubMed ID: 4195523
    [No Abstract]   [Full Text] [Related]  

  • 35. The current status of immunosuppressive therapy.
    Mannick JA
    Surgery; 1970 Apr; 67(4):711-9. PubMed ID: 4190986
    [No Abstract]   [Full Text] [Related]  

  • 36. Manipulation of allograft immunogenicity by pretreatment of cadaver donors.
    Guttmann RD
    Urol Clin North Am; 1976 Oct; 3(3):475-90. PubMed ID: 790729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of rabbit ATG in cadaver kidney transplantation: an updated report with consideration of presensitized recipients.
    Davis RC; Nabseth DC; Olsson CA; Idelson BA; Schmitt GW; Cho SI; Mannick JA
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):67-70. PubMed ID: 4612906
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of high doses of soluble Urbason in the treatment of renal transplants].
    Cucchiara G; Alfani D; Antonacci V; Berloco P; Famulari A; Sturniolo A; Rizzo F
    Minerva Med; 1980 Feb; 71(4):269-72. PubMed ID: 6986588
    [No Abstract]   [Full Text] [Related]  

  • 39. [The role of histocompatibility and antilymphocyte globulins in the early development of human renal homotransplantation].
    Van Ypersele de Strihou ; Alexandre GP; Coche E; Sokal G
    J Urol Nephrol (Paris); 1969 Sep; 75(9):608-15. PubMed ID: 4103961
    [No Abstract]   [Full Text] [Related]  

  • 40. [Liver transplantation].
    Mikaeloff P
    Bull Soc Int Chir; 1967 Sep; 26(5):489-95. PubMed ID: 4913603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.